Join
Live feed
·
INSIDERFilingvia Quantisnow
AIM ImmunoTech Inc. logo

SEC Form 4: Equels Thomas K bought $10,000 worth of shares (14,993 units at $0.67), increasing direct ownership by 3% to 575,938 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AIM (AIM ImmunoTech Inc.) and more on Quantisnow.

SEC Form 4: Equels Thomas K bought $10,000 worth of shares (14,993 units at $0.67), increasing direct ownership by 3% to 575,938 units | Quantisnow